Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy

Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Crescenzo, Francesco, Marastoni, Damiano, Bovo, Chiara, Calabrese, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335234/
https://www.ncbi.nlm.nih.gov/pubmed/32650121
http://dx.doi.org/10.1016/j.msard.2020.102372
_version_ 1783554101246689280
author Crescenzo, Francesco
Marastoni, Damiano
Bovo, Chiara
Calabrese, Massimiliano
author_facet Crescenzo, Francesco
Marastoni, Damiano
Bovo, Chiara
Calabrese, Massimiliano
author_sort Crescenzo, Francesco
collection PubMed
description Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and severity of COVID-19 (confirmed and possible) in pwMS followed at the Veneto Regional MS Center in Verona (Italy), an area most stricken by COVID-19. In our sample size, the prevalence of COVID-19 seems to be much higher than that officially reported at the regional level on the general population, but it also characterized by a favourable course.
format Online
Article
Text
id pubmed-7335234
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73352342020-07-06 Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy Crescenzo, Francesco Marastoni, Damiano Bovo, Chiara Calabrese, Massimiliano Mult Scler Relat Disord Commentary Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. Currently, there are no conclusive data in this regard. We report the prevalence and severity of COVID-19 (confirmed and possible) in pwMS followed at the Veneto Regional MS Center in Verona (Italy), an area most stricken by COVID-19. In our sample size, the prevalence of COVID-19 seems to be much higher than that officially reported at the regional level on the general population, but it also characterized by a favourable course. Elsevier B.V. 2020-09 2020-07-04 /pmc/articles/PMC7335234/ /pubmed/32650121 http://dx.doi.org/10.1016/j.msard.2020.102372 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Crescenzo, Francesco
Marastoni, Damiano
Bovo, Chiara
Calabrese, Massimiliano
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title_full Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title_fullStr Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title_full_unstemmed Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title_short Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy
title_sort frequency and severity of covid-19 in multiple sclerosis: a short single-site report from northern italy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335234/
https://www.ncbi.nlm.nih.gov/pubmed/32650121
http://dx.doi.org/10.1016/j.msard.2020.102372
work_keys_str_mv AT crescenzofrancesco frequencyandseverityofcovid19inmultiplesclerosisashortsinglesitereportfromnorthernitaly
AT marastonidamiano frequencyandseverityofcovid19inmultiplesclerosisashortsinglesitereportfromnorthernitaly
AT bovochiara frequencyandseverityofcovid19inmultiplesclerosisashortsinglesitereportfromnorthernitaly
AT calabresemassimiliano frequencyandseverityofcovid19inmultiplesclerosisashortsinglesitereportfromnorthernitaly

Ejemplares similares